Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives

Long Xuan Zhao; Tae Sung Kim; Soo Hyun Ahn; Tae Hyung Kim; Eun kyung Kim; Won Jea Cho; Heesung Choi; Chong Soon Lee; Jung Ae Kim; Tae Cheon Jeong; Ching jer Chang; Eung Seok Lee

doi:10.1016/S0960-894X(01)00531-5

Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives

Long Xuan Zhao, Tae Sung Kim, Soo Hyun Ahn, Tae Hyung Kim, Eun kyung Kim, Won Jea Cho, Heesung Choi, Chong Soon Lee, Jung Ae Kim, Tae Cheon Jeong, Ching jer Chang, Eung Seok Lee

Research output: Contribution to journal › Article › peer-review

76 Citations (Scopus)

Abstract

For the development of new anticancer agents, 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives were designed and evaluated for their topoisomerase I inhibitory activity and antitumor cytotoxicity. Structure-activity relationship studies indicated that 2,2′:6′,2″-terpyridine derivatives were highly cytotoxic toward several human tumor cell lines, whereas 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives were potent topoisomerase I inhibitors.

Original language	English
Pages (from-to)	2659-2662
Number of pages	4
Journal	Bioorganic and Medicinal Chemistry Letters
Volume	11
Issue number	19
DOIs	https://doi.org/10.1016/S0960-894X(01)00531-5
Publication status	Published - 2001 Oct 8
Externally published	Yes

ASJC Scopus subject areas

Biochemistry
Molecular Medicine
Molecular Biology
Pharmaceutical Science
Drug Discovery
Clinical Biochemistry
Organic Chemistry

Access to Document

10.1016/S0960-894X(01)00531-5

Cite this

Zhao, L. X., Kim, T. S., Ahn, S. H., Kim, T. H., Kim, E. K., Cho, W. J., Choi, H., Lee, C. S., Kim, J. A., Jeong, T. C., Chang, C. J., & Lee, E. S. (2001). Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives. Bioorganic and Medicinal Chemistry Letters, 11(19), 2659-2662. https://doi.org/10.1016/S0960-894X(01)00531-5

Zhao, LX, Kim, TS, Ahn, SH, Kim, TH, Kim, EK, Cho, WJ, Choi, H, Lee, CS, Kim, JA, Jeong, TC, Chang, CJ & Lee, ES 2001, 'Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives', Bioorganic and Medicinal Chemistry Letters, vol. 11, no. 19, pp. 2659-2662. https://doi.org/10.1016/S0960-894X(01)00531-5

@article{ce9e475d0b174cf18e2d2978947b6743,

title = "Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives",

abstract = "For the development of new anticancer agents, 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives were designed and evaluated for their topoisomerase I inhibitory activity and antitumor cytotoxicity. Structure-activity relationship studies indicated that 2,2′:6′,2″-terpyridine derivatives were highly cytotoxic toward several human tumor cell lines, whereas 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives were potent topoisomerase I inhibitors.",

author = "Zhao, {Long Xuan} and Kim, {Tae Sung} and Ahn, {Soo Hyun} and Kim, {Tae Hyung} and Kim, {Eun kyung} and Cho, {Won Jea} and Heesung Choi and Lee, {Chong Soon} and Kim, {Jung Ae} and Jeong, {Tae Cheon} and Chang, {Ching jer} and Lee, {Eung Seok}",

note = "Funding Information: This work was supported by a grant (HMP-00-B-21500-0110) from the Ministry of Health and Welfare, R.O.K. ",

year = "2001",

month = oct,

day = "8",

doi = "10.1016/S0960-894X(01)00531-5",

language = "English",

volume = "11",

pages = "2659--2662",

journal = "Bioorganic and Medicinal Chemistry Letters",

issn = "0960-894X",

publisher = "Elsevier Limited",

number = "19",

}

TY - JOUR

T1 - Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives

AU - Zhao, Long Xuan

AU - Kim, Tae Sung

AU - Ahn, Soo Hyun

AU - Kim, Tae Hyung

AU - Kim, Eun kyung

AU - Cho, Won Jea

AU - Choi, Heesung

AU - Lee, Chong Soon

AU - Kim, Jung Ae

AU - Jeong, Tae Cheon

AU - Chang, Ching jer

AU - Lee, Eung Seok

N1 - Funding Information: This work was supported by a grant (HMP-00-B-21500-0110) from the Ministry of Health and Welfare, R.O.K.

PY - 2001/10/8

Y1 - 2001/10/8

N2 - For the development of new anticancer agents, 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives were designed and evaluated for their topoisomerase I inhibitory activity and antitumor cytotoxicity. Structure-activity relationship studies indicated that 2,2′:6′,2″-terpyridine derivatives were highly cytotoxic toward several human tumor cell lines, whereas 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives were potent topoisomerase I inhibitors.

AB - For the development of new anticancer agents, 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives were designed and evaluated for their topoisomerase I inhibitory activity and antitumor cytotoxicity. Structure-activity relationship studies indicated that 2,2′:6′,2″-terpyridine derivatives were highly cytotoxic toward several human tumor cell lines, whereas 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives were potent topoisomerase I inhibitors.

UR - http://www.scopus.com/inward/record.url?scp=0035829148&partnerID=8YFLogxK

U2 - 10.1016/S0960-894X(01)00531-5

DO - 10.1016/S0960-894X(01)00531-5

M3 - Article

C2 - 11551772

AN - SCOPUS:0035829148

SN - 0960-894X

VL - 11

SP - 2659

EP - 2662

JO - Bioorganic and Medicinal Chemistry Letters

JF - Bioorganic and Medicinal Chemistry Letters

IS - 19

ER -

Synthesis, topoisomerase I inhibition and antitumor cytotoxicity of 2,2′:6′,2″-, 2,2′:6′,3″- and 2,2′:6′,4″-terpyridine derivatives

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this